The effect of captopril on definitive patients with coronavirus pneumonia

Phase 3

Recruiting

• Conditions: Coronavirus pneumonia.; This code assigned to a disease diagnosis of COVID-19 confirmed by laboratory testing; U07.1

• Registration Number: IRCT20140824018915N9
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

COVID-19 disease confirmed by imaging (HRCT) or Real Time PCR

Exclusion Criteria

Pregnancy
Breastfeeding
Bilateral renal artery stenosis
Hereditary angioedema
Psoriasis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of oxygen secretion. Timepoint: At the beginning of the study (before the intervention) and 14 days after the start of taking captopril. Method of measurement: Using a pulse oximeter.;Mortality rate. Timepoint: At the end of hospitalization of patients. Method of measurement: According to the physician report.;Duration of hospitalization. Timepoint: At the end of hospitalization of patients. Method of measurement: Calculated by the physician.